Steward Partners Investment Advisory, LLC Rocket Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 11,340 shares of RCKT stock, worth $76,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,340
Previous 6,700
69.25%
Holding current value
$76,318
Previous $84,000
10.71%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
256Shares Held
107MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$119 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$85 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$44.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$41.7 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$35 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $509M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...